WINTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
WINDTREE THERAPEUTICS INC /DE/
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 19, 2025
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $26.68K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.1288 (−99.23%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2025
Valuation
- Market cap
- $26.68K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -57783.23%
Fundamentals
- Net income
- -$39.99M
- Free cash flow
- -$15.41M
- Book value per share
- -$0.44
- Diluted shares
- 27M
Fifteen years at a glance
Fiscal years 2010 to 2024 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$33.50M
Net income
-$39.99M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months